West Pharmaceutical Services Inc. ($WST) Stock Forecast: Up 5.7% Today

What is West Pharmaceutical Services Inc.?

West Pharmaceutical Services Inc. ($WST) specializes in packaging components and delivery systems for injectable drugs and healthcare products. The company experienced a strong bullish movement in the market today.

Why is West Pharmaceutical Services Inc. going up?

WST stock is up 5.7% on Jan 6, 2026 14:46

• Despite executive insider selling and recent performance challenges, West Pharmaceutical Services Inc. exceeded expectations with its Q3 earnings and revenue. This likely contributed to the positive movement in the company's stock.
• The growing investments from North Growth Management Ltd. and Ethic Inc. in WST suggest increasing confidence in the company's future, especially with the optimistic FY2025 guidance provided.
• Thermo Fisher Scientific Inc. ($TMO) recently announced a quarterly dividend and a stock buyback program, potentially boosting market sentiment towards healthcare companies, including WST.
• In summary, West Pharmaceutical Services Inc.'s bullish stock movement today could be attributed to its strong financial performance, increased stake acquisitions, and positive developments in the healthcare sector.

WST Price Chart

WST Technical Analysis

WST News

Cynosure Group LLC Sells 5,293 Shares of Thermo Fisher Scientific Inc. $TMO

Cynosure Group LLC significantly reduced its stake in Thermo Fisher Scientific Inc. ($TMO) by selling 5,293 shares, marking a 69.3% decrease in its holdings during the third quarter. This comes amidst substantial insider selling, with executives like EVP Frederick M. Lowery and CEO Marc N. Casper divesting shares totaling over $86.5 million in the past 90 days. Despite this, Thermo Fisher has announced a $5.0 billion stock buyback program, declared a $0.43 quarterly dividend, and exceeded quarterly earnings expectations, setting positive FY2025 guidance.

https://www.marketbeat.com/instant-alerts/filing-cynosure-group-llc-sells-5293-shares-of-thermo-fisher-scientific-inc-tmo-2026-01-05/

West Pharmaceutical Services, Inc. $WST Shares Acquired by North Growth Management Ltd.

North Growth Management Ltd. increased its stake in West Pharmaceutical Services (NYSE:WST) by 17.2% in the third quarter, bringing its total holdings to 34,000 shares valued at $8.93 million. This makes WST the fund's 28th-largest position. West Pharmaceutical Services reported Q3 EPS of $1.96, surpassing analyst estimates, and announced a quarterly dividend of $0.22 per share.

https://www.marketbeat.com/instant-alerts/filing-west-pharmaceutical-services-inc-wst-shares-acquired-by-north-growth-management-ltd-2026-01-04/

Investing in West Pharmaceutical Services (NYSE:WST) three years ago would have delivered you a 20% gain

West Pharmaceutical Services (NYSE:WST) shareholders have seen a 19% gain over the last three years, which lags behind the overall market return. The company's earnings per share have declined by 6.8% annually over the same period, suggesting that the share price movement isn't driven by EPS growth. Additionally, the stock has experienced an 18% decrease in the past year, indicating a recent downturn in performance.

https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-wst/west-pharmaceutical-services/news/investing-in-west-pharmaceutical-services-nysewst-three-year/amp

Investing in West Pharmaceutical Services (NYSE:WST) three years ago would have delivered you a 20% gain

Over three years, West Pharmaceutical Services (NYSE:WST) shares gained 19%, underperforming the overall market. The company experienced a 6.8% annualized decrease in earnings per share over the same period, despite modest 0.7% revenue growth. While the stock is well-covered by analysts, its performance suggests fundamental challenges that warrant further investigation beyond basic metrics.

https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-wst/west-pharmaceutical-services/news/investing-in-west-pharmaceutical-services-nysewst-three-year

Ethic Inc. Purchases 4,206 Shares of West Pharmaceutical Services, Inc. $WST

Ethic Inc. significantly increased its stake in West Pharmaceutical Services (NYSE:WST) by 200% in Q3, acquiring 4,206 additional shares, bringing its total holdings to 6,309 shares valued at approximately $1.655 million. West Pharmaceutical Services surpassed Q3 earnings and revenue estimates and provided positive FY2025 guidance. The company maintains a "Moderate Buy" consensus rating from analysts with an average target price of $342.20.

https://www.marketbeat.com/instant-alerts/filing-ethic-inc-purchases-4206-shares-of-west-pharmaceutical-services-inc-wst-2026-01-02/

Trending Today

Axie Infinity ($AXS) Crypto Forecast: Down 5.2% Today

Dash ($DASH) Crypto Forecast: Up 34.6% Today

Internet Computer ($ICP) Crypto Forecast: Up 26.2% Today

Shiba Inu ($SHIB) Crypto Forecast: Down 5.0% Today

Litecoin ($LTC) Crypto Forecast: Down 6.6% Today

Ethereum ($ETH) Crypto Forecast: Up 5.0% Today

Biogen Inc. ($BIIB) Stock Forecast: Down 5.3% Today

Crude Oil ($CRUDE) Commodity Forecast: Down 2.8% Today

Gasoline ($GASOLINE) Commodity Forecast: Down 2.9% Today

Heating Oil ($HEATOIL) Commodity Forecast: Down 2.3% Today

West Pharmaceutical Services Inc. Price History

24.06.2025 - WST Stock was up 23.7%

• WST stock surged as the company reported a strong Q2 earnings beat, driven by an increase in earnings per share due to tariff and foreign exchange benefits.
• Revenue growth in the Proprietary Products segment played a key role in the positive market movement, signaling robust demand for high-value products like GLP-1 and SmartDose.
• Investor sentiment remains upbeat about West Pharmaceutical's ability to sustain growth in Q2, buoyed by ongoing strength in critical segments.
• Bullish investor confidence today was likely strengthened by the favorable earnings outlook and segmental performance expectations for West Pharmaceutical Services, Inc.

06.05.2025 - WST Stock was up 5.5%

• The bullish movement in WST stock could be attributed to investors' optimism regarding the pending class action lawsuit.
• The reminder of the lawsuit deadline might have sparked confidence in the market, indicating that the company is taking necessary legal actions to address any potential issues.
• This proactive approach from West Pharmaceutical Services, Inc. could have reassured investors and led to increased buying interest, driving the stock price higher.
• Overall, the market's positive reaction to the news of the pending class action lawsuit reflects investor confidence in the company's ability to handle legal challenges effectively.

24.01.2025 - WST Stock was up 5.3%

• WST experienced a bullish movement due to its identification as one of the top health care stocks with considerable growth potential this month.
• The stock being oversold in the health care sector attracted investors seeking undervalued opportunities.
• The Relative Strength Index (RSI), a momentum indicator, boosted trader confidence, resulting in increased buying pressure and a rise in the stock price.
• Positive market sentiment towards the health care sector and specific company analysis likely played a role in the notable bullish movement observed in WST.

06.00.2026 - WST Stock was up 5.7%

• Despite executive insider selling and recent performance challenges, West Pharmaceutical Services Inc. exceeded expectations with its Q3 earnings and revenue. This likely contributed to the positive movement in the company's stock.
• The growing investments from North Growth Management Ltd. and Ethic Inc. in WST suggest increasing confidence in the company's future, especially with the optimistic FY2025 guidance provided.
• Thermo Fisher Scientific Inc. ($TMO) recently announced a quarterly dividend and a stock buyback program, potentially boosting market sentiment towards healthcare companies, including WST.
• In summary, West Pharmaceutical Services Inc.'s bullish stock movement today could be attributed to its strong financial performance, increased stake acquisitions, and positive developments in the healthcare sector.

21.10.2025 - WST Stock was up 5.1%

• The decrease in short interest indicates a positive sentiment among investors towards WST.
• The reduction in shares sold short could suggest that investors are becoming more confident in the company's future prospects.
• This decrease in short interest may have contributed to increased buying pressure on WST, leading to its bullish movement today.

23.06.2025 - WST Stock was up 5.3%

• WST's strong bullish movement today could be attributed to the market's anticipation of steady growth in Q2 earnings, driven by the high demand for GLP-1 and SmartDose products.
• Investors may be optimistic about WST's segmental edge holding up, leading to increased confidence in the company's performance.
• The focus on innovation and meeting the demand for healthcare products could be positioning WST favorably in the market, attracting investor interest and driving the stock's upward movement.

10.06.2025 - WST Stock was up 4.0%

• The rise in WST's stock price could be due to investors' growing confidence in the company's ability to manage the class action lawsuit situation.
• Initially, the announcement of investors having the chance to lead a class action lawsuit caused uncertainty and a decrease in the stock price.
• However, as more investors engage legal support to discuss their rights before the deadline, it suggests a potential positive resolution for the company, leading to the stock's upward movement.
• This scenario emphasizes the significance of monitoring legal developments and investor sentiment alongside the company's operational performance when evaluating stock fluctuations.

04.03.2025 - WST Stock was down 6.5%

• Despite the positive surge in ProDex (PDEX) stock, WST experienced a bearish movement.
• The lack of indication for further gains in ProDex might have caused investors to reallocate their funds, leading to a sell-off in WST.
• Investors may have shifted focus from WST to ProDex, anticipating better returns based on the recent surge in PDEX stock price.
• This shift in market sentiment towards ProDex could have contributed to the bearish movement in WST as investors sought potentially more lucrative opportunities in the market.

22.03.2025 - WST Stock was up 5.4%

• WST had a strong bullish movement today due to expectations of strong segmental performance in the first quarter, driven by growth in pharmaceutical stabilization, biologics rebound, and contract manufacturing gains.
• The market is likely reacting positively to the potential growth and stability in the pharmaceutical sector, which is a key market for West Pharmaceutical Services.
• Investors are optimistic about the company's ability to capitalize on the increased demand for injectable drug administration solutions, especially in the current global health landscape.

23.09.2025 - WST Stock was up 14.5%

• The bullish movement in WST could be attributed to the anticipation of strong Q3 earnings driven by robust demand for GLP-1 and biologics products.
• Investors seem optimistic about WST's ability to navigate challenges such as labor constraints, tariffs, and plant shutdowns, which might have positively impacted the stock price.
• The market may be pricing in the potential for WST to outperform expectations despite margin pressures, showcasing confidence in the company's resilience and growth prospects.

23.09.2025 - WST Stock was up 10.7%

• WST stock experienced a bullish movement today due to the company's strong Q3 earnings beat and raised EPS outlook, driven by robust demand and favorable foreign exchange rates.
• The market responded positively to the company's solid growth in Proprietary Products, reflecting investors' confidence in West Pharmaceutical's ability to capitalize on market opportunities.
• Despite potential challenges such as labor constraints, tariffs, and plant shutdowns, the momentum in GLP-1 and biologics demand seems to have outweighed any margin pressure concerns, further boosting investor sentiment towards WST stock.

06.10.2025 - WST Stock was down 4.0%

• Analysts are bullish on WST, predicting a potential surge of 25.41% in the stock price.
• Despite positive analyst sentiment, the market may have reacted to other factors causing a bearish movement in WST.
• It is possible that external market conditions or unforeseen events impacted WST negatively, leading to the bearish trend observed today.